Granfeldt H, Solem J O, Lönn U, Peterzén B, Carnstam B, Dahlström U, Jansson K, Koul B, Steen S, Toom M
Linköping Heart Center, University Hospital, Sweden.
Ann Thorac Surg. 1995 Feb;59(2 Suppl):S52-5. doi: 10.1016/0003-4975(94)00905-m.
Four transplant candidates fulfilling the Food and Drug Administration criteria for a permanent left ventricular assist device received a pneumatic HeartMate system as a bridge to heart transplantation. All patients survived and were fully rehabilitated at the time of transplantation, which was carried out 2 to 6 months after the initial operation. There were no major complications associated with the procedures. We are impressed by the effectiveness and safety of the device.
四名符合美国食品药品监督管理局永久性左心室辅助装置标准的移植候选人接受了气动HeartMate系统作为心脏移植的桥梁。所有患者均存活，并在初次手术后2至6个月进行心脏移植时完全康复。这些手术没有出现重大并发症。该装置的有效性和安全性给我们留下了深刻印象。
